U.K. Stock News

LSE:BATS
LSE:BATSTobacco

Has The Rally In British American Tobacco (LSE:BATS) Left Much Value On The Table?

If you are wondering whether British American Tobacco at £48.75 is still offering value or if the easy money has already been made, the starting point is to look closely at what the current price actually implies. The stock has posted returns of 0.2% over the last 7 days, 13.3% over 30 days, 16.4% year to date and 55.4% over 1 year, with longer term returns of 132.1% over 3 years and 163.7% over 5 years, which naturally raises questions about how much of the story is already priced...
LSE:AV.
LSE:AV.Insurance

Aviva Expands Canadian Underwriting As Investors Weigh Valuation And Dividend Risk

Aviva (LSE:AV) is expanding its Canadian underwriting operations through the integration of Volante Global’s Canadian team into Probitas Canada. The combined operation will be supported by leadership from Aviva UK & Ireland, with the aim of increasing underwriting capacity and technical capability in Canada. This move is intended to strengthen Aviva’s ability to write more complex risks in a key international market. Aviva’s share price is currently around £6.256, with the stock up 9.0%...
AIM:LBG
AIM:LBGEntertainment

Highlighting 3 UK Penny Stocks With Market Caps Over £70M

The UK market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market fluctuations, certain investment opportunities remain compelling. Penny stocks, often associated with smaller or newer companies, continue to offer potential growth when backed by strong financial health. In this context, we will explore three UK penny stocks that stand out for their robust balance sheets...
LSE:GSK
LSE:GSKPharmaceuticals

Assessing GSK (LSE:GSK) Valuation After Recent Share Price Weakness And Long Term Gains

Recent share performance and business scale Without a specific headline event driving GSK (LSE:GSK) today, it is useful to look at how the stock has been behaving recently and how that compares with the size of the underlying business. GSK’s share price has risen about 0.8% over the past day and 2.2% over the past week, while it is down around 8% over the past month and 13.5% over the past 3 months. Over longer horizons, the stock shows a year-to-date total return of 4.5%, around 39.1% over...